<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">When comparing with the control group, administrating antiviral therapy prior or during the third trimester did not show clear difference from others on the incidence of congenital malformation rate, prematurity rate, Apgar scores &lt; 8, fetal death, and low birth weight (Fig. S11).</p>
